| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f1ca1a18ab17167ddd6cdec1b4d96c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
| filingDate |
2008-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d491c3e63111ba86fcbc19b312ce67d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e32b1264fd9d74e865071c333be2083b |
| publicationDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008260863-A1 |
| titleOfInvention |
Compositions for mucociliary clearance and methods for administering same |
| abstract |
Sterile, preservative-free premeasured hypertonic saline solutions may be administered to individuals afflicted with cystic fibrosis to increase mucolciliary clearance and to improve lung function. In particular, a 7% hypertonic saline solution may be administered at least 2 times a day, using a jet and/or vibrating-mesh nebulizer to an individual afflicted with cystic fibrosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018296509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2978434-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11724050-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3360547-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014296641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018111903-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8602025-B2 |
| priorityDate |
2007-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |